Aroma profile
How it Smells
The aroma of beta-caryophyllene is described as:
Effects
Linked Effects
These effects are based on early-stage research in animals and cells. They are not proven in humans. Do not change your treatment based on this information.
About
What is Beta-Caryophyllene?
Beta-caryophyllene is unique among terpenes. While most terpenes add to the cannabis experience through aroma and indirect effects, beta-caryophyllene can directly activate a receptor in the body called CB2. This is the same type of receptor that CBD works on. Because of this, some scientists classify it as a dietary cannabinoid as well as a terpene (Hashiesh et al., 2021).
It is a sesquiterpene, meaning it is a larger molecule than monoterpenes like myrcene or limonene. This makes it less volatile and it tends to linger in the smell of a strain longer. Its aroma is immediately recognisable: the sharp, spicy heat of freshly ground black pepper (Booth and Bohlmann, 2019).
Effects in detail
What the Research Says
Because beta-caryophyllene binds to CB2 receptors, it can influence inflammation and immune responses. CB2 receptors are found mainly outside the brain, particularly in immune cells, which means BCP can affect inflammation without causing psychoactive effects (Hashiesh et al., 2021).
Preclinical studies have found potential benefits for pain relief, anxiety reduction, and even neuroprotection. Russo (2011) identified it as one of the most clinically interesting terpenes precisely because of its direct receptor activity. Research is ongoing into its potential for conditions involving chronic pain and inflammation.
Everyday sources
Where You Find it in Daily Life
Black pepper is the richest everyday source. When you smell a pepper grinder, the spicy, slightly woody warmth is beta-caryophyllene. Cloves and cinnamon also contain high amounts, and it is a significant component of oregano, basil, and rosemary.
Copaiba oil, used in traditional Amazonian medicine and now sold as a wellness supplement, contains very high concentrations of beta-caryophyllene. Some researchers studying copaiba's anti-inflammatory properties believe BCP is the active ingredient responsible for its effects.
Research
Key Studies
The landmark paper that established beta-caryophyllene as a CB2 agonist was published by Gertsch et al. (2008), though it is cited through Hashiesh et al. (2021) in this guide's scope. Hashiesh and colleagues reviewed the broad pharmacological evidence and concluded that BCP has significant therapeutic potential for inflammatory and neuropathic conditions.
Baram et al. (2022) confirmed that BCP activates CB2 at concentrations found in cannabis products, strengthening the case for its clinical relevance. Its non-psychoactive nature makes it particularly interesting as a potential therapeutic target.
References
- Baram, L. et al. (2022) 'Major cannabis terpenes, applied individually and in combination, activate endogenous cannabinoid CB1 and CB2 receptors', Frontiers in Pharmacology, 13, 1040962. doi: 10.3389/fphar.2022.1040962.
- Booth, J.K. and Bohlmann, J. (2019) 'Terpenes in Cannabis sativa: from plant genome to humans', Plant Science, 284, pp. 67-72. doi: 10.1016/j.plantsci.2019.03.022.
- Hashiesh, H.S. et al. (2021) 'A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene', Biomedicine and Pharmacotherapy, 140, 111639. doi: 10.1016/j.biopha.2021.111639.
- Russo, E.B. (2011) 'Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects', British Journal of Pharmacology, 163(7), pp. 1344-1364. doi: 10.1111/j.1476-5381.2011.01238.x.
